305 related articles for article (PubMed ID: 29773273)
21. Pulmonary Manifestations of Systemic Vasculitis in Children.
Cuceoglu MK; Ozen S
Pediatr Clin North Am; 2021 Feb; 68(1):167-176. PubMed ID: 33228930
[TBL] [Abstract][Full Text] [Related]
22. Management of Small Vessel Vasculitides.
Lopalco G; Rigante D; Venerito V; Emmi G; Anelli MG; Lapadula G; Iannone F; Cantarini L
Curr Rheumatol Rep; 2016 Jun; 18(6):36. PubMed ID: 27118389
[TBL] [Abstract][Full Text] [Related]
23. Classification and diagnostic criteria in systemic vasculitis.
Saleh A; Stone JH
Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):209-21. PubMed ID: 15857792
[TBL] [Abstract][Full Text] [Related]
24. An approach to the diagnosis and management of systemic vasculitis.
Miller A; Chan M; Wiik A; Misbah SA; Luqmani RA
Clin Exp Immunol; 2010 May; 160(2):143-60. PubMed ID: 20070316
[TBL] [Abstract][Full Text] [Related]
25. Classification and classification criteria for vasculitis: achievements, limitations and prospects.
Mahr A; de Menthon M
Curr Opin Rheumatol; 2015 Jan; 27(1):1-9. PubMed ID: 25415531
[TBL] [Abstract][Full Text] [Related]
26. [Recent advance in vasculitis syndrome].
Kobayashi S; Hashimoto H
Nihon Rinsho; 1999 Feb; 57(2):388-92. PubMed ID: 10078011
[TBL] [Abstract][Full Text] [Related]
27. [Systemic vasculitides: some debatable aspects of the problem].
Shilkina NP
Ter Arkh; 2015; 87(5):100-105. PubMed ID: 26155627
[TBL] [Abstract][Full Text] [Related]
28. Non-infectious orbital vasculitides.
Perumal B; Black EH; Levin F; Servat JJ
Eye (Lond); 2012 May; 26(5):630-9. PubMed ID: 22361845
[TBL] [Abstract][Full Text] [Related]
29. Nomenclature of cutaneous vasculitides - German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
Sunderkötter C; Lamprecht P; Mahr A; Metze D; Zelger B
J Dtsch Dermatol Ges; 2018 Dec; 16(12):1425-1432. PubMed ID: 30537317
[TBL] [Abstract][Full Text] [Related]
30. Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul Bacon.
Misra R
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():49-52. PubMed ID: 30698354
[TBL] [Abstract][Full Text] [Related]
31. Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients.
Sharma A; Mittal T; Rajan R; Rathi M; Nada R; Minz RW; Joshi K; Sakhuja V; Singh S
Int J Rheum Dis; 2014 May; 17(4):408-11. PubMed ID: 24188067
[TBL] [Abstract][Full Text] [Related]
32. [Primary childhood vasculitis--new classification criteria].
Herlin T; Nielsen S
Ugeskr Laeger; 2008 Sep; 170(36):2784-7. PubMed ID: 18761873
[TBL] [Abstract][Full Text] [Related]
33. Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.
Guillevin L
Clin Exp Nephrol; 2013 Oct; 17(5):622-627. PubMed ID: 24018402
[TBL] [Abstract][Full Text] [Related]
34. L17. What can we expect from the revised Chapel Hill consensus conference nomenclature of vasculitis?
Jennette JC
Presse Med; 2013 Apr; 42(4 Pt 2):550-5. PubMed ID: 23453204
[No Abstract] [Full Text] [Related]
35. The last classification of vasculitis.
Kallenberg CG
Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):5-10. PubMed ID: 18172778
[TBL] [Abstract][Full Text] [Related]
36. [Hypocomplementemic urticarial vasculitis].
Jachiet M; Flageul B; Bouaziz JD; Bagot M; Terrier B;
Rev Med Interne; 2018 Feb; 39(2):90-98. PubMed ID: 28457680
[TBL] [Abstract][Full Text] [Related]
37. [Ocular manifestations of primary systemic vasculitis].
Barbosa-Cobos RE; Recillas-Gispert C; Arellanes-García L
Reumatol Clin; 2011 Dec; 7 Suppl 3():S12-7. PubMed ID: 22119276
[TBL] [Abstract][Full Text] [Related]
38. Management of Primary Small-Vessel Vasculitis.
Nwannunu CE; Shah R; Limmer AL
Skin Therapy Lett; 2020 May; 25(3):5-8. PubMed ID: 32510891
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
40. The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides.
Box CD; Cronin O; Hauser B
Front Endocrinol (Lausanne); 2022; 13():806361. PubMed ID: 35250864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
